Gabriel Piedrafita

Dr. Gabriel Piedrafita


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2021 in Nature
Verified
Journal Article
Closed access
PDF file
BCB. Colom
B. Colom
AHA. Herms
A. Herms
MHM. W. J. Hall
M. W. J. Hall
SDS. C. Dentro
S. C. Dentro
CKC. King
C. King
PJP. H. Jones
P. H. Jones

18 May 2020 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
BCBartomeu Colom
Bartomeu Colom
MAMaria P. Alcolea
Maria P. Alcolea
GPGabriel Piedrafita
Gabriel Piedrafita
MHMichael W. J. Hall
Michael W. J. Hall
AWAgnieszka Wabik
Agnieszka Wabik
PJPhilip H. Jones
Philip H. Jones

19 January 2023 in Nature Genetics
Verified
Journal Article
Open access
PDF file
EAEmilie Abby
Emilie Abby
SDStefan C. Dentro
Stefan C. Dentro
MHMichael W. J. Hall
Michael W. J. Hall
JFJoanna C. Fowler
Joanna C. Fowler
SOSwee Hoe Ong
Swee Hoe Ong
PJPhilip H. Jones
Philip H. Jones
NOTCH1 mutant clones occupy the majority of normal human esophagus by middle age but are comparatively rare in esophageal cancers, suggesting NOTCH1 mutations drive clonal expansion but impede carcinogenesis. Here we test this hypothesis. Sequencing NOTCH1 mutant clones in aging human esophagus reveals frequent biallelic mutations that block NOTCH1 signaling. In mouse esophagus, heterozygous Notch1 mutation confers a competitive advantage over wild-type cells, an effect enhanced by loss of the second allele. Widespread Notch1 loss alters transcription but has minimal effects on the epithelial structure and cell dynamics. In a carcinogenesis model, Notch1 mutations were less prevalent in tumors than normal epithelium. Deletion of Notch1 reduced tumor growth, an effect recapitulated by anti-NOTCH1 antibody treatment. Notch1 null tumors showed reduced proliferation. We conclude that Notch1 mutations in normal epithelium are beneficial as wild-type Notch1 favors tumor expansion. NOTCH1 blockade may have therapeutic potential in preventing esophageal squamous cancer.

1 August 2015 in Current Opinion in Biotechnology
Verified
Journal Article
Open access
MKMarkus A Keller
Markus A Keller
GPGabriel Piedrafita
Gabriel Piedrafita
MRMarkus Ralser
Markus Ralser
Enzymes shape cellular metabolism, are regulated, fast, and for most cases specific. Enzymes do not however prevent the parallel occurrence of non-enzymatic reactions. Non-enzymatic reactions were important for the evolution of metabolic pathways, but are retained as part of the modern metabolic network. They divide into unspecific chemical reactivity and specific reactions that occur either exclusively non-enzymatically as part of the metabolic network, or in parallel to existing enzyme functions. Non-enzymatic reactions resemble catalytic mechanisms as found in all major enzyme classes and occur spontaneously, small molecule (e.g. metal-) catalyzed or light-induced. The frequent occurrence of non-enzymatic reactions impacts on stability and metabolic network structure, and has thus to be considered in the context of metabolic disease, network modeling, biotechnology and drug design.

1 September 2019 in Cell Stem Cell
Verified
Journal Article
Open access
DFDavid Fernandez-Antoran
David Fernandez-Antoran
GPGabriel Piedrafita
Gabriel Piedrafita
KMKasumi Murai
Kasumi Murai
SOSwee Hoe Ong
Swee Hoe Ong
AHAlbert Herms
Albert Herms
PJPhilip H. Jones
Philip H. Jones
As humans age, normal tissues, such as the esophageal epithelium, become a patchwork of mutant clones. Some mutations are under positive selection, conferring a competitive advantage over wild-type cells. We speculated that altering the selective pressure on mutant cell populations may cause them to expand or contract. We tested this hypothesis by examining the effect of oxidative stress from low-dose ionizing radiation (LDIR) on wild-type and p53 mutant cells in the transgenic mouse esophagus. We found that LDIR drives wild-type cells to stop proliferating and differentiate. p53 mutant cells are insensitive to LDIR and outcompete wild-type cells following exposure. Remarkably, combining antioxidant treatment and LDIR reverses this effect, promoting wild-type cell proliferation and p53 mutant differentiation, reducing the p53 mutant population. Thus, p53-mutant cells can be depleted from the normal esophagus by redox manipulation, showing that external interventions may be used to alter the mutational landscape of an aging tissue.

18 March 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
GPGabriel Piedrafita
Gabriel Piedrafita
VKVasiliki Kostiou
Vasiliki Kostiou
AWAgnieszka Wabik
Agnieszka Wabik
BCBartomeu Colom
Bartomeu Colom
DFDavid Fernandez-Antoran
David Fernandez-Antoran
PJPhilip H. Jones
Philip H. Jones
In adult skin epidermis and the epithelium lining the esophagus cells are constantly shed from the tissue surface and replaced by cell division. Tracking genetically labelled cells in transgenic mice has given insight into cell behavior, but conflicting models appear consistent with the results. Here, we use an additional transgenic assay to follow cell division in mouse esophagus and the epidermis at multiple body sites. We find that proliferating cells divide at a similar rate, and place bounds on the distribution cell cycle times. By including these results in a common analytic approach, we show that data from eight lineage tracing experiments is consistent with tissue maintenance by a single population of proliferating cells. The outcome of a given cell division is unpredictable but, on average, the likelihood of producing proliferating and differentiating cells is equal, ensuring cellular homeostasis. These findings are key to understanding squamous epithelial homeostasis and carcinogenesis.